EG15599A - Process for the preparation of immunoglobulin conjugates - Google Patents

Process for the preparation of immunoglobulin conjugates

Info

Publication number
EG15599A
EG15599A EG8207A EG782A EG15599A EG 15599 A EG15599 A EG 15599A EG 8207 A EG8207 A EG 8207A EG 782 A EG782 A EG 782A EG 15599 A EG15599 A EG 15599A
Authority
EG
Egypt
Prior art keywords
immunoglobulin
preparation
immunoglobulin conjugates
conjugates
fragment
Prior art date
Application number
EG8207A
Other languages
English (en)
Inventor
Fernand Rowland Georges
George Simmonds Robin
Original Assignee
Lilly Industries Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Industries Ltd filed Critical Lilly Industries Ltd
Application granted granted Critical
Publication of EG15599A publication Critical patent/EG15599A/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/68—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an antibody, an immunoglobulin or a fragment thereof, e.g. an Fc-fragment
    • A61K47/6801—Drug-antibody or immunoglobulin conjugates defined by the pharmacologically or therapeutically active agent
    • A61K47/6803—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates
    • A61K47/6805—Drugs conjugated to an antibody or immunoglobulin, e.g. cisplatin-antibody conjugates the drug being a vinca alkaloid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • External Artificial Organs (AREA)
EG8207A 1981-01-12 1982-01-06 Process for the preparation of immunoglobulin conjugates EG15599A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB8100847 1981-01-12

Publications (1)

Publication Number Publication Date
EG15599A true EG15599A (en) 1986-06-30

Family

ID=10518931

Family Applications (1)

Application Number Title Priority Date Filing Date
EG8207A EG15599A (en) 1981-01-12 1982-01-06 Process for the preparation of immunoglobulin conjugates

Country Status (27)

Country Link
EP (1) EP0056322B1 (cs)
JP (1) JPS57136529A (cs)
KR (1) KR860001149B1 (cs)
AT (1) ATE16603T1 (cs)
AU (1) AU549495B2 (cs)
BG (1) BG40318A3 (cs)
CA (1) CA1180660A (cs)
CS (1) CS235525B2 (cs)
DD (1) DD201447A5 (cs)
DE (1) DE3267474D1 (cs)
DK (1) DK5982A (cs)
EG (1) EG15599A (cs)
ES (1) ES8304149A1 (cs)
FI (1) FI820020A7 (cs)
GB (1) GB2090837B (cs)
GR (1) GR75182B (cs)
HU (1) HU186025B (cs)
IE (1) IE52239B1 (cs)
IL (1) IL64722A (cs)
MX (1) MX7215E (cs)
NZ (1) NZ199421A (cs)
PH (1) PH18031A (cs)
PL (1) PL128529B1 (cs)
PT (1) PT74252B (cs)
RO (1) RO82758B (cs)
SU (1) SU1069628A3 (cs)
ZA (1) ZA82122B (cs)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4639456A (en) * 1980-06-10 1987-01-27 Omnichem S.A. Vinblastin-23-oyl amino acid derivatives
CA1203164A (en) * 1982-03-09 1986-04-15 Thomas J. Mckearn Antibody conjugates
DE3482444D1 (de) * 1983-03-30 1990-07-19 Lilly Industries Ltd Immunoglobulinkonjugate.
DK167984A (da) * 1983-03-30 1984-10-01 Lilly Industries Ltd Alkaloidderivater
EP0124502B1 (fr) * 1983-04-29 1991-06-12 OMNICHEM Société anonyme Nouveaux conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques contenant ces conjugués
GB2148299B (en) * 1983-09-01 1988-01-06 Hybritech Inc Antibody compositions of therapeutic agents having an extended serum half-life
US4667030A (en) * 1985-06-17 1987-05-19 Eli Lilly And Company Hydrazide succinimide derivatives of antineoplastic indole-dihydroindole alkaloids
US4675400A (en) * 1985-06-17 1987-06-23 Eli Lilly And Company Bifunctional derivatives of 4-desacetyl indole-dihydroindole alkaloids
FI860456A7 (fi) * 1985-07-16 1987-01-17 Huhtamaeki Oy Laeaeketehdas Le Bis-indolalkaloiders proteinkonjugat, bis-indolalkaloider, deras framstaellning och anvaendning.
EP0232693A3 (fr) * 1985-12-16 1988-04-06 La Region Wallonne Conjugués de la vinblastine et de ses dérivés, procédé pour leur préparation et compositions pharmaceutiques les contenant
ZA873600B (en) * 1986-05-27 1988-12-28 Lilly Co Eli Immunoglobulin conjugates
US4801688A (en) * 1986-05-27 1989-01-31 Eli Lilly And Company Hydrazone immunoglobulin conjugates
FR2626882B1 (fr) * 1988-02-08 1991-11-08 Ire Celltarg Sa Conjugues de derives de vinca comportant une chaine detergente en position c-3
US5094849A (en) * 1988-08-08 1992-03-10 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized vinca analogs via simple organic linkers
US5144012A (en) * 1988-08-08 1992-09-01 Eli Lilly And Company Cytotoxic drug conjugates
US5006652A (en) * 1988-08-08 1991-04-09 Eli Lilly And Company Intermediates for antibody-vinca drug conjugates
US5028697A (en) * 1988-08-08 1991-07-02 Eli Lilly And Company Cytotoxic antibody conjugates of hydrazide derivatized methotrexate analogs via simple organic linkers
US5043340A (en) * 1990-04-03 1991-08-27 Eli Lilly And Company Derivatives of 4-desacetyl VLB C-3 carboxhydrazide

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2456224A1 (de) * 1974-11-28 1976-08-12 Karl Dr Med Theurer Verwendung von nativen antikoerpern oder von antikoerper-fragmenten mit kovalent gebundenen oder konjugierten zytostatisch und/bzw. oder zytotoxisch wirkenden substanzen fuer die krebstherapie
GB1446536A (en) * 1975-02-21 1976-08-18 Yeda Res & Dev Pharmaceutically active compositions
FR2349335A1 (fr) * 1976-04-28 1977-11-25 Inst Int Pathologie Cellulaire Complexes d'alcaloides bis-indoliques du type vinblastine avec la tubuline, leur procede d'obtention et leur utilisation
IT1107772B (it) * 1977-08-22 1985-11-25 Cancer Res Inst Royal Procedimento per la produzione di complessi macromolecolari prodotto ottenuto e composizioni farmaceutiche che lo contengono come ingrediente attivo
FR2437213A1 (fr) * 1978-09-28 1980-04-25 Cm Ind Produits cytotoxiques formes par liaison covalente de la chaine a de la ricine avec un anticorps et leur procede de preparation
JPS55136235A (en) * 1979-04-09 1980-10-23 Teijin Ltd Antitumor protein complex and its preparation

Also Published As

Publication number Publication date
MX7215E (es) 1988-01-08
EP0056322A1 (en) 1982-07-21
DD201447A5 (de) 1983-07-20
DK5982A (da) 1982-07-13
RO82758B (ro) 1984-01-30
ATE16603T1 (de) 1985-12-15
PT74252A (en) 1982-02-01
IL64722A (en) 1985-07-31
BG40318A3 (bg) 1986-11-14
PT74252B (en) 1983-08-24
SU1069628A3 (ru) 1984-01-23
NZ199421A (en) 1984-08-24
IE820023L (en) 1982-07-12
HU186025B (en) 1985-05-28
GB2090837B (en) 1984-07-18
JPS57136529A (en) 1982-08-23
CA1180660A (en) 1985-01-08
AU549495B2 (en) 1986-01-30
PL128529B1 (en) 1984-02-29
DE3267474D1 (en) 1986-01-02
EP0056322B1 (en) 1985-11-21
FI820020L (fi) 1982-07-13
FI820020A7 (fi) 1982-07-13
RO82758A (ro) 1984-01-14
PH18031A (en) 1985-03-06
ZA82122B (en) 1983-07-27
ES508633A0 (es) 1983-02-16
IL64722A0 (en) 1982-03-31
CS235525B2 (en) 1985-05-15
KR830008684A (ko) 1983-12-12
PL234695A1 (cs) 1982-07-19
IE52239B1 (en) 1987-08-19
ES8304149A1 (es) 1983-02-16
KR860001149B1 (ko) 1986-08-18
AU7927482A (en) 1982-07-22
GR75182B (cs) 1984-07-13
GB2090837A (en) 1982-07-21

Similar Documents

Publication Publication Date Title
EG15599A (en) Process for the preparation of immunoglobulin conjugates
DE3372175D1 (en) Covalent conjugates of an enzyme and an antibody, and medicinal compositions containing these conjugates
NZ241217A (en) Acid-labile linker compounds derived from maleamic acids.
ATE58297T1 (de) Kupplungsmittel zum radiomarkieren von proteinen.
GR1000712B (el) Νεα αντισωματα που αντιδρουν με τα ανθρωπινα καρκινωματα.
DE3885317D1 (de) Makromolekulare Platin-Antitumorverbindungen.
DK0462145T3 (da) Covalente konjugater mellem lipid og oligonucleotid
IL71366A (en) Immunoglobulin conjugates with vincaleukoblastine derivatives,their production and pharmaceutical compositions containing them
HUT51594A (en) Process for production of celates and their complexes containing ortolizating functional groups, compositions containing such active substances and process for production of conjugates consisting of one complex and linked to it antibody or fragment of antibody
FR2432038A1 (fr) Conjugues marques d'hydrazide d'acide naphtalene-1,2-dicarboxylique chimioluminescent et leur procede de preparation
HU184736B (en) Process for preparing anticarcinogenic immunoglobuline derivatives
HU9302309D0 (en) Process for producing conjugates of bicyclo-polyaza-macrocyclo-carboxylic acid complexes and contrast-materials containing them
HU9302312D0 (en) Process for producing bicycloaza-macrocyclo-phosphonic acids, conjugates and contrast materials containing them
IL79260A (en) Process and composition for activation of immune response cells to be used in the treatment of cancer,non-malignant tumors,infections,and immune deficiencies
ES2110481T3 (es) Procedimiento para la obtencion de acidos sialicos activados.
ES8103760A1 (es) Procedimiento de preparacion de (20 s) - 3 - - ((aminoace- til)amino)-5 - - pregnan- 20 - ol
GB1515392A (en) Process for the purification of protein conjugates
RU93053897A (ru) Комплексы бициклополиазамакроциклокарбоновых кислот, их конъюгаты, фармацевтическая композиция, способ диагностики, набор и способ получения